Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19

Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19

Bibliographic Details
Main Authors:	Bovijn, J, Lindgren, CM, Holmes, MV
Format:	Journal article
Language:	English
Published:	Elsevier 2020

Similar Items

Using human genetics to guide the repurposing of medicines
by: Bovijn, J, et al.
Published: (2020)

Commentary: Mendelian randomization and women's health
by: Censin, JC, et al.
Published: (2019)

Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins
by: Censin, JC, et al.
Published: (2021)

Structural insights into IL-6 signaling inhibition by therapeutic antibodies
by: Mingxing Wang, et al.
Published: (2024-03-01)

Causal relevance of obesity on the leading causes of death in women and men: A Mendelian randomization study
by: Censin, JC, et al.
Published: (2019)

Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
by: Bovijn, J, et al.
Published: (2020)

Causal relationships between obesity and the leading causes of death in women and men
by: Censin, JC, et al.
Published: (2019)

Network analyses: Inhibition of androgen receptor signaling reduces inflammation in the lung through AR-MAF-IL6 signaling axes
by: Albert R. Wang, et al.
Published: (2024-05-01)

Response to comment on “Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics”
by: Bovijn, J, et al.
Published: (2021)

Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors
by: Dirk Schmidt-Arras, et al.
Published: (2021-06-01)

Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer
by: Bharti, Rashmi, et al.
Published: (2016)

A variant in IL6ST with a selective IL-11 signaling defect in human and mouse
by: Schwerd, T, et al.
Published: (2020)

Structural insights into IL-11-mediated signalling and human IL6ST variant-associated immunodeficiency
by: Scott Gardner, et al.
Published: (2024-03-01)

Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients
by: Rossella Salemi, et al.
Published: (2022-05-01)

The use of human genetics in drug target identification and validation
by: Bovijn, J
Published: (2021)

Inhibition of IL-6 signaling pathway by curcumin in uterine decidual cells.
by: Y Sangeeta Devi, et al.
Published: (2015-01-01)

Joint Reconstituted Signaling of the IL-6 Receptor via Extracellular Vesicles
by: Philipp Arnold, et al.
Published: (2020-05-01)

IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3
by: Ran Lv, et al.
Published: (2017-08-01)

A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19
by: Bo Gong, et al.
Published: (2022-04-01)

A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
by: Jason A. Hackney, et al.
Published: (2023-10-01)

Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
by: Kristine Pettersen, et al.
Published: (2017-05-01)

Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130
by: Anissa A. Widjaja, et al.
Published: (2024-01-01)

Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest
by: Praveen Anand, et al.
Published: (2022-03-01)

Lifelong genetically lowered sclerostin and risk of cardiovascular disease
by: Bovijn, J, et al.
Published: (2019)

Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling
by: Michael Tang, et al.
Published: (2015-12-01)

Inhibiting IL-6 in COVID-19: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-07-01)

Exercise-induced vitamin D receptor and androgen receptor mediate inhibition of IL-6 and STAT3 in muscle
by: Seiji Hashimoto, et al.
Published: (2024-03-01)

Genome-wide association study identifies 48 common genetic variants associated with handedness
by: Cuellar-Partida, G, et al.
Published: (2020)

Traversing through the Mechanistic Event Analysis in IL-6 and IL-17 Signaling for a New Therapeutic Paradigm in NSCLC
by: Riya Khilwani, et al.
Published: (2024-01-01)

Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas
by: Chih-Yu Peng, et al.
Published: (2022-01-01)

Identification and Characterization of a Novel IL-4 Receptor α Chain (IL-4Rα) Antagonist to Inhibit IL-4 Signalling
by: Nayyar Ahmed, et al.
Published: (2015-05-01)

Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)
by: A Seda Yılmaz-Eliş, et al.
Published: (2013-01-01)

Search for a Functional Genetic Variant Mimicking the Effect of SGLT2 Inhibitor Treatment
by: Siqi Wang, et al.
Published: (2021-07-01)

Distinct signal transduction processes by IL-4 and IL-13 and influences from the Q551R variant of the human IL-4 receptor alpha chain
by: Braun Sandra, et al.
Published: (2002-08-01)

Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases.
by: Ricardo C Ferreira, et al.
Published: (2013-04-01)

Association of Interleukin-6(IL-6) and IL-10 genetic polymorphism with the severity of COVID-19 patients
by: Mahmoud El-Bendary, et al.
Published: (2023-11-01)

IL-6 Signaling in Monocytes: A Potential Therapeutic Avenue for Stress-Induced Mood Impairments
by: Anzela Niraula, et al.
Published: (2019-08-01)

Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis
by: Luis Sainz, et al.
Published: (2023-11-01)

The role of vitamin D receptor and IL‐6 in COVID‐19
by: Ali Azmi, et al.
Published: (2023-07-01)

An interleukin 10 Receptor alpha (IL-10RA) variant with a compound heterozygote mutation shows normal IL-10 signaling activity
by: Jiajia Lv, et al.
Published: (2023-05-01)